For Long Life

With about $70 million in financing, Craig Venter has launched a new company called Human Longevity that plans to combine omic and clinical data to develop diagnostics and therapies for aging-related diseases and allow people to live longer, GenomeWeb Daily News reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.